187 related articles for article (PubMed ID: 24281690)
1. Design and evaluation of a PEGylated lipopeptide equipped with drug-interactive motifs as an improved drug carrier.
Zhang P; Lu J; Huang Y; Zhao W; Zhang Y; Zhang X; Li J; Venkataramanan R; Gao X; Li S
AAPS J; 2014 Jan; 16(1):114-24. PubMed ID: 24281690
[TBL] [Abstract][Full Text] [Related]
2. Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity.
Zhang Y; Huang Y; Zhao W; Lu J; Zhang P; Zhang X; Li J; Gao X; Venkataramanan R; Li S
AAPS J; 2014 Nov; 16(6):1282-91. PubMed ID: 25193267
[TBL] [Abstract][Full Text] [Related]
3. Improved Micellar Formulation for Enhanced Delivery for Paclitaxel.
Xu J; Zhang X; Chen Y; Huang Y; Wang P; Wei Y; Ma X; Li S
Mol Pharm; 2017 Jan; 14(1):31-41. PubMed ID: 28043124
[TBL] [Abstract][Full Text] [Related]
4. A PEG-Fmoc conjugate as a nanocarrier for paclitaxel.
Zhang P; Huang Y; Liu H; Marquez RT; Lu J; Zhao W; Zhang X; Gao X; Li J; Venkataramanan R; Xu L; Li S
Biomaterials; 2014 Aug; 35(25):7146-56. PubMed ID: 24856103
[TBL] [Abstract][Full Text] [Related]
5. PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel.
Zhang X; Lu J; Huang Y; Zhao W; Chen Y; Li J; Gao X; Venkataramanan R; Sun M; Stolz DB; Zhang L; Li S
Bioconjug Chem; 2013 Mar; 24(3):464-72. PubMed ID: 23425093
[TBL] [Abstract][Full Text] [Related]
6. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z
Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876
[TBL] [Abstract][Full Text] [Related]
7. Co-Delivery of Paclitaxel by a Capsaicin Prodrug Micelle Facilitating for Combination Therapy on Breast Cancer.
Lan Y; Sun Y; Yang T; Ma X; Cao M; Liu L; Yu S; Cao A; Liu Y
Mol Pharm; 2019 Aug; 16(8):3430-3440. PubMed ID: 31199661
[TBL] [Abstract][Full Text] [Related]
8. Sodium cholate-enhanced polymeric micelle system for tumor-targeting delivery of paclitaxel.
Zhang X; Wu Y; Zhang M; Mao J; Wu Y; Zhang Y; Yao J; Xu C; Guo W; Yu B
Int J Nanomedicine; 2017; 12():8779-8799. PubMed ID: 29263668
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
[TBL] [Abstract][Full Text] [Related]
10. PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers.
Lu J; Huang Y; Zhao W; Marquez RT; Meng X; Li J; Gao X; Venkataramanan R; Wang Z; Li S
Biomaterials; 2013 Feb; 34(5):1591-600. PubMed ID: 23182923
[TBL] [Abstract][Full Text] [Related]
11. Poly(ethylene glycol)-block-poly(d,l-lactic acid) micelles containing oligo(lactic acid)
Tam YT; Shin DH; Chen KE; Kwon GS
J Control Release; 2019 Mar; 298():186-193. PubMed ID: 30790593
[TBL] [Abstract][Full Text] [Related]
12. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.
Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A
Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785
[TBL] [Abstract][Full Text] [Related]
13. PEG-Fmoc-Ibuprofen Conjugate as a Dual Functional Nanomicellar Carrier for Paclitaxel.
Zhao M; Huang Y; Chen Y; Xu J; Li S; Guo X
Bioconjug Chem; 2016 Sep; 27(9):2198-205. PubMed ID: 27532881
[TBL] [Abstract][Full Text] [Related]
14. Nanoassembly of surfactants with interfacial drug-interactive motifs as tailor-designed drug carriers.
Gao X; Huang Y; Makhov AM; Epperly M; Lu J; Grab S; Zhang P; Rohan L; Xie XQ; Wipf P; Greenberger J; Li S
Mol Pharm; 2013 Jan; 10(1):187-98. PubMed ID: 23244299
[TBL] [Abstract][Full Text] [Related]
15. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
16. Development and in vitro/in vivo evaluation of a novel targeted polymeric micelle for delivery of paclitaxel.
Emami J; Rezazadeh M; Hasanzadeh F; Sadeghi H; Mostafavi A; Minaiyan M; Rostami M; Davies N
Int J Biol Macromol; 2015 Sep; 80():29-40. PubMed ID: 26093319
[TBL] [Abstract][Full Text] [Related]
17. Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles.
Shi Y; van der Meel R; Theek B; Oude Blenke E; Pieters EH; Fens MH; Ehling J; Schiffelers RM; Storm G; van Nostrum CF; Lammers T; Hennink WE
ACS Nano; 2015; 9(4):3740-52. PubMed ID: 25831471
[TBL] [Abstract][Full Text] [Related]
18. PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel.
Zhang X; Huang Y; Zhao W; Chen Y; Zhang P; Li J; Venkataramanan R; Li S
Mol Pharm; 2014 Aug; 11(8):2807-14. PubMed ID: 24987803
[TBL] [Abstract][Full Text] [Related]
19. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
20. Chondroitin Sulfate-Derived Paclitaxel Nanocrystal via π-π Stacking with Enhanced Stability and Tumor Targetability.
Huang D; Gui J; Chen X; Yu R; Gong T; Zhang Z; Fu Y
ACS Appl Mater Interfaces; 2022 Nov; 14(46):51776-51789. PubMed ID: 36350778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
